(NYSE: PRGO) Perrigo Co's forecast annual revenue growth rate of 0.58% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 8.35%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.59%.
Perrigo Co's revenue in 2026 is $4,144,900,000.On average, 6 Wall Street analysts forecast PRGO's revenue for 2026 to be $573,810,828,075, with the lowest PRGO revenue forecast at $549,248,671,710, and the highest PRGO revenue forecast at $593,654,830,110. On average, 6 Wall Street analysts forecast PRGO's revenue for 2027 to be $578,112,674,670, with the lowest PRGO revenue forecast at $547,305,902,280, and the highest PRGO revenue forecast at $602,258,523,300.
In 2028, PRGO is forecast to generate $586,022,521,635 in revenue, with the lowest revenue forecast at $551,746,518,120 and the highest revenue forecast at $614,331,447,615.